Analysis of Inventory
Paying user area
Try for free
CVS Health Corp. pages available for free this week:
- Balance Sheet: Assets
- Common-Size Income Statement
- Analysis of Profitability Ratios
- Analysis of Long-term (Investment) Activity Ratios
- DuPont Analysis: Disaggregation of ROE, ROA, and Net Profit Margin
- Analysis of Reportable Segments
- Capital Asset Pricing Model (CAPM)
- Operating Profit Margin since 2005
- Price to Sales (P/S) since 2005
- Aggregate Accruals
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to CVS Health Corp. for $24.99.
This is a one-time payment. There is no automatic renewal.
We accept:
Inventory Disclosure
CVS Health Corp., balance sheet: inventory
US$ in millions
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
- Inventories
- Over the five-year period ending December 31, 2024, inventories exhibited a fluctuating trend. Initially, inventories decreased from 18,496 million USD in 2020 to 17,760 million USD in 2021, representing a modest decline. This was followed by a noticeable increase to 19,090 million USD in 2022, marking the highest point within the period. Subsequently, inventories declined again in 2023 to 18,025 million USD and demonstrated a slight uptick in 2024, reaching 18,107 million USD. Overall, the values remained relatively stable, with fluctuations generally contained within the range of approximately 17,700 to 19,100 million USD.